Patent details

301139 Product Name: Selumetinibwaterstofsulfaat, desgewenst in watervrije vorm of in de vorm van een solvaat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301139
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1968948
Status:
SPC granted but not yet in force
Application number:
301139
Procedural language:
Dutch
First Applicant Residence Country:
Sweden (SE)

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1552
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/06/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
27/10/2021
First Marketing Authorization date:
19/06/2021
Grant date:
22/02/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/10/2021
SPC/SPC Extension Expiration Date:
11/12/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
27/10/2021
 
 

 

Name:
AstraZeneca AB
Address:
-, 151 85 SÖDERTÄLJE, Sweden (SE)

From:
27/10/2021
 
 

 

Name:
Array Biopharma, Inc.
Address:
3200 Walnut Street, BOULDER, CO 80301, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
27/10/2021
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
08/22
Publication date:
23/02/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
44/21
Publication date:
03/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/12/2026
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
22/02/2022 SPC Documents Certificate SPC 1 PDF /9/9/4/7/3/0800737499/docs/301139_7_supplprotectioncertificate20220222033051600.pdf
22/02/2022 Outgoing Correspondence Decision grant 1 PDF /9/9/4/7/3/0800737499/docs/301139_8_463943l504a.pdf
21/02/2022 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /9/9/4/7/3/0800737499/docs/301139_6_incomingcorrespondencepaper20220221123720343.pdf
30/12/2021 Outgoing Correspondence Letter to applicant 2 PDF /9/9/4/7/3/0800737499/docs/301139_5_453608l173.pdf
27/10/2021 SPC Documents Annex SPC 2 PDF /9/9/4/7/3/0800737499/docs/301139_0_supplprotectioncertificate20211027025532358.pdf
27/10/2021 Application Form First filed application form 2 PDF /9/9/4/7/3/0800737499/docs/301139_1_applicationform20211027025227173.pdf
27/10/2021 SPC Documents Marketing Authorization SPC 3 PDF /9/9/4/7/3/0800737499/docs/301139_2_supplprotectioncertificate20211027025419037.pdf
27/10/2021 SPC Documents Summary of the characteristics of the product 18 PDF /9/9/4/7/3/0800737499/docs/301139_3_supplprotectioncertificate20211027025352566.pdf
27/10/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /9/9/4/7/3/0800737499/docs/301139_4_442803l174.pdf